QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Im, W. B. Articles by Dinh, D. M. Search for Related Content PubMed PubMed Citation Articles by Im, W. B. Articles by Dinh, D. M.

Positive Allosteric Modulator of the Human 5-HT_2C Receptor

Biology II/Neurobiology, Pharmacia, Kalamazoo, Michigan (W.B.I., C.L.C., G.L.A.) and Research and Development Discovery Technologies (D.M.D.), Pharmacia, Kalamazoo, Michigan

The human 5-hydroxytryptamine-2C (5-HT_2C) receptor has been the target of potential anxiolytics and antiobesity drugs, and its positive allosteric modulator was discovered to be L-threo--D-galacto-octopyranoside, methyl-7-chloro-6,7,8-trideoxy-6-[[(4-undecyl-2-piperidinyl)carbonyl]amino]-1-thiomonohydrochloride (2S-cis) (PNU-69176E). The drug at low micromolar concentrations (<25 µM) markedly enhanced [³H]5-HT binding (more than 300%) by increasing its affinity for low-affinity sites but with no appreciable effect on antagonist ([³H]mesulergine) binding. Functionally, PNU-69176E alone rendered receptors constitutively active, producing the pheno-types of 5-HT–activated receptors, as measured with mesulergine-sensitive guanosine 5'-O-(3-[³⁵S]thio)triphosphate binding, transient inositol 1,4,5-triphosphate release, and [³H]inositol phosphate accumulation. These actions of PNU-69176E were observed with the human 5-HT_2C receptor expressed in several mammalian cell lines (human embryonic kidney 293, NIH3T3, and SH-EP) at variable receptor densities (6 to 45 pmol/mg of protein), but not with analogous 5-HT and dopamine receptors (human 5-HT_2A, 5-HT_2B, 5-HT₆, 5-HT₇, and dopamine D2-long and D3 receptors). Structurally, PNU-69176E consists of a long alkyl chain and a polar moiety, including the -D-galactopyranoside. Its analogs with shorter alkyl chains (methyl to n-hexyl instead of n-undecyl group) failed to enhance [³H]5-HT binding, and also long alkyl amides are without allosteric modulation. We propose that PNU-69176E may represent a new class of membrane receptor modulators, which probably need a long alkyl chain as a membrane anchor and target a selective polar head group to receptor modulatory sites near the membrane surface.

Address correspondence to: Dr. Wha Bin Im, BiologyII/Neurobiology, 0216-209-512, Pharmacia, 301 Henrietta Street, Kalamazoo, MI 49007. E-mail: wbim{at}am.pnu.com

This article has been cited by other articles:

				V. Avlani, L. T. May, P. M. Sexton, and A. Christopoulos Application of a Kinetic Model to the Apparently Complex Behavior of Negative and Positive Allosteric Modulators of Muscarinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1062 - 1072. [Abstract] [Full Text] [PDF]